[go: up one dir, main page]

ES2120499T3 - Derivado de eritromicina. - Google Patents

Derivado de eritromicina.

Info

Publication number
ES2120499T3
ES2120499T3 ES93910399T ES93910399T ES2120499T3 ES 2120499 T3 ES2120499 T3 ES 2120499T3 ES 93910399 T ES93910399 T ES 93910399T ES 93910399 T ES93910399 T ES 93910399T ES 2120499 T3 ES2120499 T3 ES 2120499T3
Authority
ES
Spain
Prior art keywords
represents hydrogen
lower alkyl
pair
same
erythromycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93910399T
Other languages
English (en)
Inventor
Hiroshi Koga
Tsutomu Sato
Hisanori Takanashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2120499T3 publication Critical patent/ES2120499T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN COMPUESTO REPRESENTADO POR LA FORMULA GENERAL [1] O UNA SAL DEL MISMO, ESTANDO EXTREMADAMENTE REDUCIDA EN LA DESCOMPOSABILIDAD POR EL ACIDO GASTRICO SI SE COMPARA CON OTROS DERIVADOS DE ERITROMICIN CONOCIDOS Y QUE TIENE UNA ACTIVIDAD EXCELENTE PARA PROMOVER EL MOVIMIENTO DE TRACTOS DIGESTIVOS, EN DONDE R1 REPRESENTA HIDROGENO, HIDROXI, ACILOXI O AMINO O ALTERNATIVAMENTE R2 Y R3 SE COMBINAN JUNTOS PARA REPRESENTAN =0 O =NOR10, EN DONDE R10 REPRESENTA HIDROGENO O UN ALQUILO INFERIOR; R4 REPRESENTA HIDROGENO O UN ALQUILO INFERIOR; E Y REPRESENTA -NR5R6 O -N+R7R8R9X-, EN DONDE R5, R6, R7, R8 Y R9 PUEDEN SER EL MISMO O DIFERENTE UNO DE OTRO Y CADA UNO REPRESENTA HIDROGENO, ALQUILO INFERIOR OPCIONALMENTE SUSTITUIDO, ALQUENILO INFERIOR, ALQUINILO INFERIOR O CICLOALQUILO, O UN GRUPO HETEROCICLICO DE 3 A 7 MIEMBROS QUE CONTIENE OXIGENO, NITROGENO O AZUFRE COMO HETEROATOMO, Y X REPRESENTA UN ANION, SIEMPRE QUE UN PAR DE R5 Y R6 Y UN PAR DE R7 Y R8 PUEDAN SER COMBINADOS CON EL ATOMO DE NITROGENO ADYACENTE PARA REPRESENTAR AZACICLOALQUILO.
ES93910399T 1992-05-26 1993-05-26 Derivado de eritromicina. Expired - Lifetime ES2120499T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13382892 1992-05-26

Publications (1)

Publication Number Publication Date
ES2120499T3 true ES2120499T3 (es) 1998-11-01

Family

ID=15113997

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93910399T Expired - Lifetime ES2120499T3 (es) 1992-05-26 1993-05-26 Derivado de eritromicina.

Country Status (20)

Country Link
US (1) US5658888A (es)
EP (1) EP0643068B1 (es)
JP (1) JP3068367B2 (es)
KR (1) KR100226311B1 (es)
CN (1) CN1036199C (es)
AT (1) ATE169927T1 (es)
AU (1) AU659740B2 (es)
CA (1) CA2117883C (es)
DE (1) DE69320476T2 (es)
DK (1) DK0643068T3 (es)
ES (1) ES2120499T3 (es)
HR (1) HRP930926B1 (es)
IL (1) IL105810A (es)
MY (1) MY113693A (es)
SG (1) SG52785A1 (es)
SI (1) SI9300281B (es)
TW (1) TW240230B (es)
WO (1) WO1993024509A1 (es)
YU (1) YU48771B (es)
ZA (1) ZA933679B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007204490A (ja) * 1995-08-03 2007-08-16 Chugai Pharmaceut Co Ltd エリスロマイシン誘導体の製造方法
ZA966601B (en) * 1995-08-03 1997-02-19 Chugai Pharmaceutical Co Ltd Process for producing erythromycin derivatives.
US6077943A (en) * 1996-03-01 2000-06-20 Takeda Chemical Industries, Ltd. Method of producing erythromycin derivative
WO1998003531A1 (fr) * 1996-07-24 1998-01-29 Chugai Seiyaku Kabushiki Kaisha Derives d'erythromycine
AU4968997A (en) * 1996-11-26 1998-06-22 Chugai Seiyaku Kabushiki Kaisha 13-membered ring macrolide compounds, medicine containing the same, and process for producing the same
US5780605A (en) * 1997-09-08 1998-07-14 Abbott Laboratories 6,9-bridged erythromycin derivatives
US6562795B2 (en) * 2000-02-18 2003-05-13 Kosan Biosciences, Inc. Motilide compounds
RU2248981C2 (ru) * 2000-09-01 2005-03-27 Чугаи Сейяку Кабусики Кайся Способ получения и очистки производных эритромицина
TWI286139B (en) * 2000-10-12 2007-09-01 Chugai Pharmaceutical Co Ltd Erythromycin derivative having novel crystal structures and processes for their production
US6906039B2 (en) 2001-06-13 2005-06-14 Ube Industries, Ltd. Process for preparation of erythromycin compounds
TW200302830A (en) * 2002-01-11 2003-08-16 Chugai Pharmaceutical Co Ltd Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US20040010035A1 (en) * 2002-07-15 2004-01-15 Ciociola Arthur A. Gastrointestinal compositions
CA2491797A1 (en) * 2002-07-10 2004-01-22 Warner-Lambert Company Llc Gastrointestinal compositions
US6986901B2 (en) * 2002-07-15 2006-01-17 Warner-Lambert Company Llc Gastrointestinal compositions
US6946482B2 (en) * 2002-08-29 2005-09-20 Kosan Biosciences, Inc. Motilide compounds
TW200420573A (en) * 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
KR20060002800A (ko) * 2003-03-05 2006-01-09 립-엑스 파마슈티칼즈, 인크. 이관능성 헤테로시클릭 화합물, 및 그의 제조 및 사용 방법
EP2210612B1 (en) 2003-06-18 2016-10-05 Ocera Therapeutics, Inc. Macrocyclic antagonists of the motilin receptor
US7407941B2 (en) * 2003-08-26 2008-08-05 Pfizer, Inc. N-desmethyl-N-substituted-11-deoxyerythromycin compounds
US20050113319A1 (en) * 2003-08-26 2005-05-26 Christopher Carreras 11-Deoxy-6,9-ether erythromycin compounds
EP1682563A1 (en) * 2003-10-30 2006-07-26 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and mehtods of making and using the same
EP1699808A1 (en) * 2003-11-18 2006-09-13 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
US7211568B2 (en) * 2003-12-18 2007-05-01 Kosan Biosciences Incorporated 9-Desoxoerythromycin compounds as prokinetic agents
US8202843B2 (en) * 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
TW200633714A (en) * 2004-12-28 2006-10-01 Chugai Pharmaceutical Co Ltd Drugs for the treatment and/or prophylaxis of gastroparesis symptom
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
WO2007025098A2 (en) 2005-08-24 2007-03-01 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
WO2007025089A2 (en) 2005-08-24 2007-03-01 Rib-X Pharmaceutical, Inc. Triazole compounds and methods of making and using the same
CA2632779A1 (en) * 2005-12-08 2007-06-14 Pfizer Inc. Method for demethylating the 3'-dimethylamino group of erythromycin compounds
CN101528765B (zh) 2006-09-11 2015-04-22 欧塞拉治疗有限公司 用于治疗胃肠动力障碍病症的促胃动素受体的大环拮抗剂
CN101547931B (zh) * 2006-12-05 2012-11-14 辉瑞有限公司 促动内酯多晶型
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60218321A (ja) * 1984-04-13 1985-11-01 Satoshi Omura 消化管収縮運動促進剤
JPS6187625A (ja) * 1984-10-05 1986-05-06 Satoshi Omura 消化管収縮運動促進剤
JPH0759513B2 (ja) * 1985-08-31 1995-06-28 北里研究所（社団法人） 消化管収縮運動促進剤
US5008249A (en) * 1985-08-31 1991-04-16 Kitasato Kenkyusho Therapeutic method of stimulating digestive tract contractile motion in mammals
DE3689758T2 (de) * 1985-08-31 1994-08-18 Kitasato Inst Erythromycinderivat und Verfahren zu dessen Herstellung.
AU656462B2 (en) * 1992-01-21 1995-02-02 Abbott Laboratories 4"-deoxyerythromycin derivatives

Also Published As

Publication number Publication date
DK0643068T3 (da) 1999-02-08
DE69320476D1 (en) 1998-09-24
HRP930926A2 (en) 1995-02-28
CN1036199C (zh) 1997-10-22
TW240230B (es) 1995-02-11
US5658888A (en) 1997-08-19
YU48771B (sh) 1999-12-27
DE69320476T2 (de) 1999-03-25
YU36693A (sh) 1996-07-24
SI9300281B (en) 2001-02-28
HRP930926B1 (en) 2000-10-31
WO1993024509A1 (fr) 1993-12-09
AU4089793A (en) 1993-12-30
CA2117883A1 (en) 1993-12-09
SI9300281A (sl) 1993-12-31
IL105810A (en) 1998-12-27
EP0643068B1 (en) 1998-08-19
AU659740B2 (en) 1995-05-25
CN1081184A (zh) 1994-01-26
KR100226311B1 (ko) 1999-10-15
IL105810A0 (en) 1993-09-22
EP0643068A4 (en) 1995-08-02
MY113693A (en) 2002-05-31
EP0643068A1 (en) 1995-03-15
CA2117883C (en) 2003-10-21
HK1009969A1 (en) 1999-09-10
JP3068367B2 (ja) 2000-07-24
SG52785A1 (en) 1998-09-28
ZA933679B (en) 1993-12-21
ATE169927T1 (de) 1998-09-15
KR950701640A (ko) 1995-04-28
JPH0656873A (ja) 1994-03-01

Similar Documents

Publication Publication Date Title
ES2120499T3 (es) Derivado de eritromicina.
ES2144421T3 (es) Nuevo derivado tetrapeptidico.
NL300374I1 (nl) Een pyrrolidylthiocarbapenemderivaat met antibacteriële werkzaamheid
ES2033049T3 (es) Procedimiento para preparar derivados de oxa- o tia-zolina.
ES2058105T3 (es) Agentes antiarritmicos.
ES2061845T3 (es) Un procedimiento para preparar un compuesto espiro.
ES311868A1 (es) Un procedimiento para preparar una sal de monoamonio de espiro (3,5-dihidroxiboroxin)-i,i-(3',5'-dihidroxiboroxina)
DK0687253T3 (da) Hidtil ukendte 4-aminopyridiner, fremgangsmåde til deres fremstilling samt lægemidler indeholdende disse forbindelser
MX9700928A (es) Derivado de triazian y medicina que lo contiene.
DK271388D0 (da) Oxetanocinereller farmakologisk acceptable salte deraf samt deres anvendelse
UY24010A1 (es) Nuevos pirrolocarbazoles
BRPI0113837B8 (pt) compostos mutilinas com atividade antimicrobiana e composição farmacêutica que os compreende
DK0392560T3 (da) Diaminoethylenforbindelser
ES2052598T3 (es) Derivados de hetaril-oxi-beta-carbolinas, su preparacion y utilizacion como medicamentos.
ES2013035A6 (es) Un metodo para preparar derivados de acilfenol.
JPS57134485A (en) Trisubstituted pyrimidopyrimidine
ES2151511T3 (es) Derivado de tiazolina.
ES2075976T3 (es) Derivados de aminoacido y su empleo como agentes antiviricos.
ES2081463T3 (es) 1-alquil-3-(acilamino)-epsilon-caprolactamas como mejoradores del aprendimiento y memoria y composiciones farmaceuticas que las contienen.
GB1474896A (en) Salts of phenylpyridazines and the preparation thereof
AR247390A1 (es) Compuestos aril-propil-aminicos dotados de alta actividad antifungica y procedimiento para producirlos
ES8802317A1 (es) Un procedimiento para preparar derivados de acido (2-aminosustituido-3-oxo-2-isoxazolidinil)-5-oxo-2-tetrahidrofuran-carboxilico
IT1223067B (it) Composto fotocromatico ed articoli fotocromatici che lo contengono
ES2150479T3 (es) Derivados de psicofuranosa y psicopiranosa.
ES418929A1 (es) Procedimiento para la preparacion de polipeptidos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 643068

Country of ref document: ES